MEET US 2026
CPHI 2026: Milan, IT | 06-08 Oct 2026
logo-dark

CMC

All about CMC

Learn about CMC analysis & quality control news and their importance to ensure precision, quality and safety when developing new pharmaceutical products.

Biosimilar Development: From Phase III to Analytical Comparability and PK/PD

Although the development of biosimilars has historically been difficult, expensive, [...]

By |2025-11-07T08:38:16+01:007. November 2025|Bioanalysis, CMC|Comments Off on Biosimilar Development: From Phase III to Analytical Comparability and PK/PD

Liraglutide & Semaglutide: Exploring Biosimilar Studies for GLP-1 receptor agonists

Liraglutide and Semaglutide have become key players in the pharmaceutical [...]

By |2025-10-30T14:02:29+01:0020. February 2024|Bioanalysis, CMC|Comments Off on Liraglutide & Semaglutide: Exploring Biosimilar Studies for GLP-1 receptor agonists

Impurity Profiling: Characterization of unknown impurities in pharmaceuticals

Characterization of unknown impurities found in pharmaceutical substances and pharmaceutical [...]

By |2024-08-29T11:46:18+02:0023. January 2024|CMC|Comments Off on Impurity Profiling: Characterization of unknown impurities in pharmaceuticals
Go to Top